leadf
logo-loader

Proactive news headlines: Sativa Wellness, OKYO Pharma, Sareum, Bahamas Petroleum...

A glance at some of the day's highlights from the Proactive Investors newswire

Sativa Wellnesss Group Inc -
Your daily round-up from the world of Proactive

Sativa Wellness Group Inc (LON:SWEL) said it has witnessed record sales in December. In a brief update, the chief executive of the cannabis and cannabidiol (CBD) wellness firm Henry Lees-Buckley said 2020 had been a “transformational year for the company” and that the company’s integrated supply chain allowed them to control quality and costs.

OKYO Pharma Limited (LON:OKYO) has appointed a chairman and a new chief executive. Industry veteran Dr Gary Jacob will assume the role of CEO, taking over from Willy Simon, who will become a senior non-executive director. Gabriele Cerrone is taking the chair of OKYO, but in a non-exec capacity.

Sareum Holdings PLC (LON:SAR) said it has been formally granted a US patent over its SDC-1802 TYK2/JAK1 kinase inhibitor programme, which is in pre-clinical development targeting cancer. It means the company’s technology is now patented in all major territories, including Europe, Japan and China.

Primary Health Properties PLC (LON:PHP) has told investors that it intends to pay four interim dividends in equal instalments of 1.55p in 2021. The level of the dividends implies a full-year dividend 6.2p, up from the 5.9p paid in 2020.

Bahamas Petroleum Company PLC (LON:BPC) told investors it is on-track to add further wells to its operations in Trinidad and also Suriname. At the same time, it confirmed on-target production with 500 barrels of oil per day being produced at the end of 2020. Now, with an extensive work programme on the slate the company is targeting production growth up to 2,500 bopd by the end of 2021.

Mkango Resources Ltd  (LON:MKA) has received approval from the TSX-Venture exchange for the issue of Mkango shares to Talaxis Limited. Talaxis is to be granted 1mln shares and in return has agreed to give up the right to buy 12mln Mkango shares at 6.6p each; Mkango shares currently trade at around 16p.

Chaarat Gold Holdings Limited (LON:CGH) has appointed Panmure Gordon as its joint corporate broker with immediate effect. Panmure will work together with the company's existing brokers Canaccord Genuity Limited and finnCap Limited. 

Destiny Pharma PLC (LON:DEST) said chairman Nick Rodgers recently purchased 9,000 ordinary shares at a price of 88p apiece. Following the transaction, his total beneficial interest is 47,462 shares, representing 0.08% of the total issued share capital of the company.

Crossword Cybersecurity PLC (LON:CCS) told investors that it will hold a webinar panel discussion on Tuesday January 12, 2021 at 10am. Entitled "Cyber Security: skills shortage, automation deficit or poor hiring practices - what's the reality?", the online discussion will bring together academics, customers and industry professionals to discuss one of the biggest challenges in the industry. It will be chaired by Dr Robert Nowill, executive chair of The Cyber Security Challenge, with a panel including Amanda Finch, CEO at The Chartered Institute of Information Security; Darren Argyle, CISRO at Standard Chartered Bank; and Stuart Jubb, Managing Director for Crossword Cybersecurity's consulting division.

Pembridge Resources PLC (LON:PERE) said an operator arrangement in relation to the Minto mine in the Yukon in Canada has been terminated as of January 1, 2021.

Argo Blockchain PLC (LON:ARB) said has received a notice of exercise of certain options and notice of exercise of certain warrants over ordinary shares, granted in connection with the company’s admission to the Official List and to trading on the Main Market. As a result, the cryptocurrency miner has issued 4.5mln shares to the holders of these options, raising £720,000.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Wellnesss Group Inc named herein, including the promotion by the Company of Sativa Wellnesss Group Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

JPD Capital and Verdex Group join forces in premium medicinal cannabis...

John-Paul Doran, CEO & Founder of JPD Capital is joined by Adam Dignan, Founder and CEO Verdex Group to explain their latest collaboration - Ibero Botanica.  Doran explains to Proactive's Katie Pilbeam, Verdex 'encapsulates all of the traits that we were looking for' in regards to...

51 minutes ago

4 min read